Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Submitted by
admin
on September 2, 2016 - 11:27am
Source:
Bloomberg
News Tags:
Pharma CEOs
Novo Nordisk
Lars Sorenson
Gilead Sciences
John Martin
Eli Lilly
John Lechleiter
GSK
Andrew Witty
Headline:
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Do Not Allow Advertisers to Use My Personal information
